Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
In this 6-year follow-up study of patients enrolled in ADVANCE, there was no evidence that intensive glucose control during the trial led to long-term benefits with respect to mortality or macrovascular events. Though event rates were small, there was a reduction in end-stage renal disease in those patients in the intensive glucose arm, hazard ratio 0.54; 95% CI, 0.34 to 0.85; P=0.007.
:
Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes
Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and Microalbuminuria
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial
Source: Nephrology Now - Category: Urology & Nephrology Authors: Nephrology Now editors Tags: Chronic Kidney Disease Diabetes Source Type: research
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Heart | Hypertension | Study | Urology & Nephrology